In colon cancer, S100A8 and S100A9 induce RAGE- and carboxylated glycan-dependent phosphorylation of ERK1/2 and SAPK/JNK, but in prostate and breast cancer, they promote p38 phosphorylation. Here, AGER is linked to malignant colon neoplasm.